You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
US President Donald Trump has threatened to cut World Health Organization funding over its pandemic response, which would affect its ability to do its work and which he might not be able to do.
The collaboration includes setting up a new testing laboratory that will investigate the use of alternative chemical reagents for test kits.
The researchers explained why the virus was given the SARS-CoV-2 name and why it is not considered a new species.
The two organizations are collaborating to perform a standardized evaluation of currently available molecular diagnostic tests to assess test performance.
Mere weeks after the 2019-nCoV sequence was released, firms, agencies, and research groups have already created PCR-based tests.
The Los Angeles Times reports that a case of the novel coronavirus making people ill in China has been reported in the US.
Sequencing analysis has tied a new coronavirus to the pneumonia outbreak occurring in China, Vox reports.
NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.
The NAM, NAS, and Royal Society have formed a commission to develop a framework on the proper use of genome editing, and convened its first meeting in Washington, DC, this week.
The World Health Organization says it accepts its panel's finding that moving forward with clinical applications of germline genome editing would be irresponsible.
Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.
The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.
In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.
According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.